RNAi Therapeutics

Pages

▼
Showing posts with label arena pharmaceuticals. Show all posts
Showing posts with label arena pharmaceuticals. Show all posts
Tuesday, July 3, 2012

Obesity Drug Approval to Unlock Low-Hanging RNAi Therapeutics Opportunities

›
The FDA approval of weight-loss drug Lorcaserin (to be sold as BELVIQ ) a week ago symbolizes a recent shift in the regulatory climate f...
›
Home
View web version
Powered by Blogger.